Familial hypercholesterolemia (FH) is a hereditary disorder characterized by high levels of cholesterol in the blood, which significantly increases the risk of developing cardiovascular diseases. This condition is caused by a disorder of lipid metabolism, most often as a result of a deficiency or dysfunction of LDL-cholesterol receptors. The concentration of low-density lipoproteins (LDL) in the blood increases significantly, which can lead to the formation of atherosclerotic plaques, myocardial infarction, stroke and other serious complications. FH can be either homozygous or heterozygous, with the homozygous form causing more severe clinical manifestations and requiring more intensive monitoring of the patient's condition.
History of the disease and interesting historical facts
The first documented information about familial hypercholesterolemia dates back to the 1930s, when doctors began to observe a link between high cholesterol and an increased risk of cardiovascular disease in families with a hereditary predisposition. Research conducted in the 1970s led to the identification of genes responsible for LDL receptor dysfunction. This breakthrough opened up new horizons in understanding the mechanism of the disease and its inheritance. Italy, in particular, stands out among countries with a high prevalence of FHC and has been the subject of numerous studies aimed at studying mutations in the gene pool of the population, which has contributed to a deeper understanding of the disease.
Epidemiology
The latest data indicate that the prevalence of familial hypercholesterolemia is approximately 1 in 300-500 people for the heterozygous form and 1 in 1 million for the homozygous form. These figures highlight the importance of early diagnosis and detection of this condition, especially in populations where hereditary diseases are highly prevalent. In some regions of the world, such as Oslo, Norway, this figure may be significantly higher. It is important to keep in mind that susceptibility to this condition may vary by race and ethnicity, which makes it more difficult to implement preventive measures and specialized programs.
Genetic predisposition to this disease
Familial hypercholesterolemia provides a striking example of Mendelian inheritance, with key genes involved in the development of the disease being LDLR, APOB, and PCSK9. Mutations in these genes disrupt the normal metabolism of cholesterol, leading to its accumulation in the blood. More than 1,500 types of mutations in the LDLR gene are known, leading to functional impairment of the LDL receptor. Based on these data, it can be argued that the inherited form of this disease is a polygenic disorder, involving more than one gene and facilitating interactions with various environmental factors.
Risk factors for the development of this disease
Although familial hypercholesterolemia is a genetic disorder, there are certain risk factors that can make the disease worse:
- Consumption of saturated fats and trans fats in the diet.
- Lack of physical activity and sedentary lifestyle.
- Smoking and alcohol abuse.
- Overweight and obesity.
- Comorbidities such as diabetes and hypertension.
These factors can not only accelerate the development of atherosclerosis, but also worsen the general condition of the patient.
Diagnosis of this disease
Diagnosis of familial hypercholesterolemia is based on clinical examination, genetic testing and laboratory studies. The main symptoms that may attract attention include:
- Dyslipidemia is a high level of LDL in the blood.
- Xanthelasma and xanthomas, as well as other manifestations of cholesterol deposits.
- Family history of cardiovascular disease in young adulthood.
Laboratory tests include:
- Lipid profile to assess cholesterol and triglyceride levels.
- Genetic testing to confirm the presence of mutations.
Radiological examinations such as ultrasound of the carotid arteries can be used to assess the extent of arterial damage. Differential diagnosis with other forms of hypercholesterolemia and metabolic disorders is also important.
Treatment
Treatment of familial hypercholesterolemia is complex and requires an individual approach. It includes:
- General treatment: dietary adjustments, increased physical activity, giving up bad habits.
- Pharmacological treatment: use of statins, fibrates, cholesterol absorption inhibitors and other agents.
- Surgical treatment: In severe cases, an atherectomy procedure or organ transplant may be required.
- Other treatments include using active prevention and education programs aimed at lifestyle changes.
List of medications used to treat this disease
The main categories of drugs used to treat familial hypercholesterolemia include:
- Statins (eg, atorvastatin, simvastatin).
- Fibrates (eg, gemfibrozil, fenofibrate).
- Cholesterol absorption inhibitors (ezetimibe).
- PCSK9 inhibitors (alirocumab, evolocumab).
- Natural products (some types of plant sterols).
Disease monitoring
Monitoring the condition of a patient with familial hypercholesterolemia includes:
- Regular monitoring of blood lipid levels.
- Evaluation of the effectiveness of treatment and possible side effects from the use of drugs.
- Assess the presence of complications such as atherosclerosis or coronary heart disease.
- The prognosis largely depends on regular monitoring and compliance with medical recommendations.
Age-related features of the disease
Familial hypercholesterolemia can occur at any age, but severe cases are more common in children and young adults. In children, symptoms may include cholesterol deposits called xanthomas and xanthelasmas that appear on the skin and around the nails. Adults, especially older adults, may experience more serious complications, such as acute coronary syndromes. However, it is important to be proactive in prevention at any age, especially if there is a family history of the disease.
Questions and Answers
- What is familial hypercholesterolemia? It is an inherited disorder characterized by high levels of cholesterol in the blood and an increased risk of cardiovascular disease.
- How is familial hypercholesterolemia diagnosed? Diagnosis of the disease includes clinical and genetic tests, as well as assessment of blood lipid levels.
- What are the possible consequences of untreated hypercholesterolemia? If left untreated, this disease can lead to atherosclerosis, heart attacks, strokes and other serious cardiovascular problems.
- What treatments are used for familial hypercholesterolemia? Treatment may include lifestyle changes, drug therapy, and in severe cases, surgery.
- How often should you check your cholesterol levels? It is recommended to carry out such checks every 3-6 months depending on the condition and the doctor’s prescription.
Dr. Oleg Korzhikov emphasizes the importance of a comprehensive approach to the treatment and prevention of familial hypercholesterolemia. It is important to monitor your diet, avoid fatty foods, and maintain physical activity. He also notes that regular checkups and following medical recommendations are the key to successfully controlling the disease. “Don’t forget that your health is in your hands,” says the doctor, urging patients to be attentive to their bodies and seek help at the first symptoms.
